Estrone and 17β-estradiol reverse breast cancer resistance protein-mediated multidrug resistance

Yasuo Imai, Satomi Tsukahara, Etsuko Ishikawa, Takashi Tsuruo, Yoshikazu Sugimoto

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Breast cancer resistance protein (BCRP), an adenosine triphosphate-binding cassette transporter, confers resistance to a series of anticancer reagents, including mitoxantrone, SN-38 and topotecan. In the present study, we found that estrone and 17β-estradiol potentiated the cytotoxicity of mitoxantrone, SN-38 and topotecan in BCRP-transduced K562 cells (K562/BCRP). These estrogens showed only a marginal effect, or none, in parental K562 cells. Estrone and 17β-estradiol increased the cellular accumulation of topotecan in K562/BCRP cells, but not in K562 cells, suggesting that these estrogens inhibit the BCRP-mediated drug efflux and overcome drug resistance.

Original languageEnglish
Pages (from-to)231-235
Number of pages5
JournalJapanese Journal of Cancer Research
Volume93
Issue number3
Publication statusPublished - 2002
Externally publishedYes

Fingerprint

P-Glycoproteins
Estrone
irinotecan
Estradiol
Topotecan
K562 Cells
Breast Neoplasms
Mitoxantrone
Proteins
Estrogens
Drug Resistance
Adenosine Triphosphate
Pharmaceutical Preparations

Keywords

  • 17β-estradiol
  • BCRP
  • Estrone
  • MDR
  • Reversal of drug resistance

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Estrone and 17β-estradiol reverse breast cancer resistance protein-mediated multidrug resistance. / Imai, Yasuo; Tsukahara, Satomi; Ishikawa, Etsuko; Tsuruo, Takashi; Sugimoto, Yoshikazu.

In: Japanese Journal of Cancer Research, Vol. 93, No. 3, 2002, p. 231-235.

Research output: Contribution to journalArticle

Imai, Yasuo ; Tsukahara, Satomi ; Ishikawa, Etsuko ; Tsuruo, Takashi ; Sugimoto, Yoshikazu. / Estrone and 17β-estradiol reverse breast cancer resistance protein-mediated multidrug resistance. In: Japanese Journal of Cancer Research. 2002 ; Vol. 93, No. 3. pp. 231-235.
@article{740dd888e5b24d42a818cb27d2f58f28,
title = "Estrone and 17β-estradiol reverse breast cancer resistance protein-mediated multidrug resistance",
abstract = "Breast cancer resistance protein (BCRP), an adenosine triphosphate-binding cassette transporter, confers resistance to a series of anticancer reagents, including mitoxantrone, SN-38 and topotecan. In the present study, we found that estrone and 17β-estradiol potentiated the cytotoxicity of mitoxantrone, SN-38 and topotecan in BCRP-transduced K562 cells (K562/BCRP). These estrogens showed only a marginal effect, or none, in parental K562 cells. Estrone and 17β-estradiol increased the cellular accumulation of topotecan in K562/BCRP cells, but not in K562 cells, suggesting that these estrogens inhibit the BCRP-mediated drug efflux and overcome drug resistance.",
keywords = "17β-estradiol, BCRP, Estrone, MDR, Reversal of drug resistance",
author = "Yasuo Imai and Satomi Tsukahara and Etsuko Ishikawa and Takashi Tsuruo and Yoshikazu Sugimoto",
year = "2002",
language = "English",
volume = "93",
pages = "231--235",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Estrone and 17β-estradiol reverse breast cancer resistance protein-mediated multidrug resistance

AU - Imai, Yasuo

AU - Tsukahara, Satomi

AU - Ishikawa, Etsuko

AU - Tsuruo, Takashi

AU - Sugimoto, Yoshikazu

PY - 2002

Y1 - 2002

N2 - Breast cancer resistance protein (BCRP), an adenosine triphosphate-binding cassette transporter, confers resistance to a series of anticancer reagents, including mitoxantrone, SN-38 and topotecan. In the present study, we found that estrone and 17β-estradiol potentiated the cytotoxicity of mitoxantrone, SN-38 and topotecan in BCRP-transduced K562 cells (K562/BCRP). These estrogens showed only a marginal effect, or none, in parental K562 cells. Estrone and 17β-estradiol increased the cellular accumulation of topotecan in K562/BCRP cells, but not in K562 cells, suggesting that these estrogens inhibit the BCRP-mediated drug efflux and overcome drug resistance.

AB - Breast cancer resistance protein (BCRP), an adenosine triphosphate-binding cassette transporter, confers resistance to a series of anticancer reagents, including mitoxantrone, SN-38 and topotecan. In the present study, we found that estrone and 17β-estradiol potentiated the cytotoxicity of mitoxantrone, SN-38 and topotecan in BCRP-transduced K562 cells (K562/BCRP). These estrogens showed only a marginal effect, or none, in parental K562 cells. Estrone and 17β-estradiol increased the cellular accumulation of topotecan in K562/BCRP cells, but not in K562 cells, suggesting that these estrogens inhibit the BCRP-mediated drug efflux and overcome drug resistance.

KW - 17β-estradiol

KW - BCRP

KW - Estrone

KW - MDR

KW - Reversal of drug resistance

UR - http://www.scopus.com/inward/record.url?scp=0036011103&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036011103&partnerID=8YFLogxK

M3 - Article

C2 - 11927002

AN - SCOPUS:0036011103

VL - 93

SP - 231

EP - 235

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 3

ER -